These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24690134)

  • 1. Response to Mitre et al.: "analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors".
    Hovorka R; Nodale M
    Diabetes Technol Ther; 2014 May; 16(5):328-9. PubMed ID: 24690134
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.
    Mitre TM; Legault L; Rabasa-Lhoret R; Haidar A
    Diabetes Technol Ther; 2014 May; 16(5):326-7. PubMed ID: 24447013
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges for outpatient closed loop studies: how to assess efficacy.
    Beck RW; Calhoun P; Kollman C
    Diabetes Technol Ther; 2013 Jan; 15(1):1-3. PubMed ID: 23297669
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.
    Hovorka R; Nodale M; Haidar A; Wilinska ME
    Diabetes Technol Ther; 2013 Jan; 15(1):4-12. PubMed ID: 23046396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amperometric glucose sensors: sources of error and potential benefit of redundancy.
    Castle JR; Ward WK
    J Diabetes Sci Technol; 2010 Jan; 4(1):221-5. PubMed ID: 20167187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the continuous glucose monitoring system to improve the management of type 1 diabetes.
    Bode BW; Hirsch IB
    Diabetes Technol Ther; 2000; 2 Suppl 1():S43-8. PubMed ID: 11469631
    [No Abstract]   [Full Text] [Related]  

  • 7. Talking Points for Helping Your Type 1 Diabetes Patient Decide About Hybrid Closed Loop.
    Perkins BA; Cardinez N; Opsteen CF
    Can J Diabetes; 2020 Jun; 44(4):356-358. PubMed ID: 31866241
    [No Abstract]   [Full Text] [Related]  

  • 8. Pascal's wager: combining continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Kerr D; Olateju T
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S43-50. PubMed ID: 20515306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE.
    Benhamou PY; Catargi B; Delenne B; Guerci B; Hanaire H; Jeandidier N; Leroy R; Meyer L; Penfornis A; Radermecker RP; Renard E; Baillot-Rudoni S; Riveline JP; Schaepelynck P; Sola-Gazagnes A; Sulmont V; Tubiana-Rufi N; Durain D; Mantovani I; Sola-Gazagnes A; Riveline JP; ; ;
    Diabetes Metab; 2012 Jul; 38 Suppl 4():S67-83. PubMed ID: 22980520
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstrations and discussions of continuous glucose monitors.
    Bode BW
    Diabetes Technol Ther; 2005 Oct; 7(5):805-8. PubMed ID: 16241888
    [No Abstract]   [Full Text] [Related]  

  • 11. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View.
    Freckmann G; Schlüter S; Heinemann L;
    J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous glucose monitoring during exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion.
    Kapitza C; Hövelmann U; Nosek L; Kurth HJ; Essenpreis M; Heinemann L
    J Diabetes Sci Technol; 2010 Jan; 4(1):123-31. PubMed ID: 20167176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorescent responsive hybrid nanogel for closed-loop control of glucose.
    Wu W; Chen S; Hu Y; Zhou S
    J Diabetes Sci Technol; 2012 Jul; 6(4):892-901. PubMed ID: 22920816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of microdialysis-based continuous glucose monitoring to drive real-time semi-closed-loop insulin infusion.
    Freckmann G; Jendrike N; Pleus S; Buck H; Bousamra S; Galley P; Thukral A; Wagner R; Weinert S; Haug C
    J Diabetes Sci Technol; 2014 Nov; 8(6):1074-80. PubMed ID: 25205589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 16. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.
    Luijf YM; DeVries JH; Zwinderman K; Leelarathna L; Nodale M; Caldwell K; Kumareswaran K; Elleri D; Allen JM; Wilinska ME; Evans ML; Hovorka R; Doll W; Ellmerer M; Mader JK; Renard E; Place J; Farret A; Cobelli C; Del Favero S; Dalla Man C; Avogaro A; Bruttomesso D; Filippi A; Scotton R; Magni L; Lanzola G; Di Palma F; Soru P; Toffanin C; De Nicolao G; Arnolds S; Benesch C; Heinemann L;
    Diabetes Care; 2013 Dec; 36(12):3882-7. PubMed ID: 24170747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose sensors: toward closed loop insulin delivery.
    Chia CW; Saudek CD
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):175-95, xi. PubMed ID: 15053902
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycaemic control in patients with type 1 diabetes after provision of public hospital-funded insulin pumps.
    Thong KY; Fegan PG; Yeap BB
    Med J Aust; 2009 Sep; 191(5):291. PubMed ID: 19740060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.